Cypress Wealth Services LLC Purchases 60 Shares of Danaher Co. (NYSE:DHR)
Cypress Wealth Services LLC lifted its position in Danaher Co. (NYSE:DHR) by 4.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,395 shares of the conglomerate’s stock after acquiring an additional 60 shares during the period. Cypress Wealth Services LLC’s holdings in Danaher were worth $314,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. RMR Wealth Builders bought a new position in Danaher during the 4th quarter valued at approximately $26,000. Inspire Advisors LLC bought a new position in Danaher during the 4th quarter valued at approximately $26,000. Hudock Inc. increased its position in Danaher by 526.3% during the 4th quarter. Hudock Inc. now owns 119 shares of the conglomerate’s stock valued at $26,000 after buying an additional 100 shares in the last quarter. SOA Wealth Advisors LLC. bought a new position in Danaher during the 4th quarter valued at approximately $29,000. Finally, Reby Advisors LLC bought a new position in Danaher during the 4th quarter valued at approximately $30,000. 78.00% of the stock is owned by institutional investors.
DHR has been the topic of several recent analyst reports. Credit Suisse Group increased their target price on Danaher from $260.00 to $264.00 and gave the company an “outperform” rating in a research note on Thursday, January 14th. KeyCorp increased their target price on Danaher from $280.00 to $315.00 and gave the company an “overweight” rating in a research note on Thursday, April 29th. Royal Bank of Canada increased their target price on Danaher from $253.00 to $285.00 and gave the company a “sector perform” rating in a research note on Friday, April 23rd. Robert W. Baird raised their price target on Danaher from $249.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, April 23rd. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised their price target on Danaher from $275.00 to $315.00 in a research note on Friday, April 23rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and thirteen have given a buy rating to the stock. Danaher presently has an average rating of “Buy” and an average price target of $265.63.
NYSE:DHR opened at $254.67 on Tuesday. The company has a quick ratio of 1.68, a current ratio of 2.08 and a debt-to-equity ratio of 0.63. The business’s 50-day simple moving average is $234.48 and its two-hundred day simple moving average is $230.73. The stock has a market cap of $181.65 billion, a PE ratio of 51.55, a P/E/G ratio of 1.92 and a beta of 0.72. Danaher Co. has a 52 week low of $155.61 and a 52 week high of $260.37.
Danaher (NYSE:DHR) last issued its earnings results on Wednesday, April 21st. The conglomerate reported $2.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.67 by $0.85. Danaher had a return on equity of 12.94% and a net margin of 18.05%. The firm had revenue of $6.87 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the previous year, the firm posted $1.05 earnings per share. The business’s revenue was up 58.2% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Co. will post 6.05 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, April 30th. Stockholders of record on Friday, March 26th were issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.33%. This is a boost from Danaher’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend was Thursday, March 25th. Danaher’s payout ratio is 19.00%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.